Publications by authors named "Winfried Fassbinder"

3 Publications

  • Page 1 of 1

Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis.

Clin Chem 2004 Jun;50(6):1071-4

Klinikum der Philipps-Universität Marburg, Department of Clinical Chemistry and Molecular Diagnostics, 35033 Marburg, Germany.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2003.030692DOI Listing
June 2004

[Chronic bilateral necrotizing and destructive granulomatous inflammatory process in the region of the paranasal sinuses and the orbita as manifestation of localized Wegener's granulomatosis].

Med Klin (Munich) 2003 Aug;98(8):453-7

Klinik für HNO-Heilkunde, Kopf- Hals- und Plastische Gesichtschirurgie, Klinikum Straubing.

Case Report: Granulomatous infectious processes have a wide differential diagnosis. This report describes the case of a 73-year-old woman who had gone through an 8-year ordeal involving several paranasal sinus operations, development of chronic facial pain, orbital exenteration of the left eye, and now threatening loss of the remaining right eye on account of progression of the chronic inflammation. Despite repeated histologic examination of ENT material by various pathologic institutes, neither the histology nor laboratory parameters were able to point us in the right direction. In the end, it was the clinical course which led to the diagnosis of Wegener's granulomatosis.

Conclusion: In chronic necrotizing granulomatous inflammatory processes in the region of the paranasal sinuses with involvement of the surrounding anatomic structures (orbit, skull base), Wegener's granulomatosis should be included in the differential diagnosis at an early stage, even if the typical signs of vasculitis and the typical antibodies are absent. The clinical course calls for an interdisciplinary treatment approach in conjunction with internists experienced in immunosuppressant therapy.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00063-003-1286-5DOI Listing
August 2003

Experience with the GENIUS hemodialysis system.

Kidney Blood Press Res 2003 ;26(2):96-9

Klinikum Fulda, Medizinische Klinik III, Fulda, Germany.

Unlabelled: The late B. Tersteegen devised a clever way to combine the advantages of a closed tank hemodialysis system with the efficacy and bacteriological safety of a single-pass system. The Teerstegen equipment is now marketed as the GENIUS hemodialysis system. For each treatment, fresh dialysis fluid is prepared according to the physician's prescription by mixing sterile ingredients (electrolytes and glucose) with preheated ultrapure water. The total amount of dialysis fluid is put into a thermally insulated glass tank (volume 75 l) of the hemodialysis machine. The filling and emptying process is completely automated. An UV radiator is used for desinfection. Due to a consequent hygienic concept, the system operates with an almost sterile and usually pyrogen-free dialysis fluid. During treatment, fresh dialysis fluid is taken from the top of the system, and the used dialysate is returned to the bottom. There is a sharp interface between the fresh and used dialysis fluids because of a small difference in temperature (1 degrees C). True volumetric ultrafiltration control is simply achieved; ultrafiltration rates between 100 and 1,000 ml/h can be selected as considered appropriate by the physician.

Microbiological Examination: We cultured more than 2,000 dialysate specimens to examine bacterial contamination, and found either no bacterial growth at all (in the vast majority of the cases) or less than 1 CFU/ml dialysate.

Clinical Experience: We have utilized the GENIUS system since 1994. Meanwhile, more than 40,000 treatments have been performed in our center. Biochemical results of the first 19 stable hemodialysis patients (mean age 66 years, range 45-82), who had been treated with conventional hemodialysis systems for at least 6 months (range 6-157) before changing to GENIUS, were evaluated. We observed an increase of mean serum albumin concentration from 4.1 (+/-0.4 SD) g/dl to 4.8 (+/-0.3) g/dl (p < 0.01) within 6 months. Most patients reported improved well-being. Of these 19 patients, 18 preferred further treatment with the GENIUS system in comparison to conventional hemodialysis machines.

Conclusion: The GENIUS hemodialysis system permits an individualized therapy of high quality; most patients prefer this system to conventional hemodialysis machines. Serum albumin levels increased significantly from normal to high normal values after change from conventional hemodialysis machines to GENIUS, probably due to less catabolic stress during the hemodialysis sessions.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1159/000070990DOI Listing
January 2004